Skip to main navigation Skip to search Skip to main content

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

  • Michel Attal
  • , Paul G. Richardson
  • , S. Vincent Rajkumar
  • , Jesus San-Miguel
  • , Meral Beksac
  • , Ivan Spicka
  • , Xavier Leleu
  • , Fredrik Schjesvold
  • , Philippe Moreau
  • , Meletios A. Dimopoulos
  • , Jeffrey Shang Yi Huang
  • , Jiri Minarik
  • , Michele Cavo
  • , H. Miles Prince
  • , Sandrine Macé
  • , Kathryn P. Corzo
  • , Frank Campana
  • , Solenn Le-Guennec
  • , Franck Dubin
  • , Kenneth C. Anderson
    • Paul G. Richardson, Vincent Rajkumar, Meletios A. Dimopoulos, Kathryn P. Corzo, Simon Harrison, Wojt Janowski, Ian Kerridge, Andrew Spencer, Michel Delforge, Karel Fostier, Philip Vlummens, Ka Lung Wu, Richard Leblanc, Michel Pavic, Michael Sebag, Roman Hajek, Vladimir Maisnar, Ludek Pour, Henrik Gregersen, Lotfi Benbouker, Denis Caillot, Martine Escoffre-Barbe, Thierry Facon, Laurent Frenzel, Cyrille Hulin, Lionel Karlin, Brigitte Kolb, Brigitte Pegourie, Aurore Perrot, Mourad Tiab, Laure Vincent, Dietger Niederwieser, Achilles Anagnostopoulos, Sosana Delimpasi, Marie Christine Kyrtsonis, Anargyros Symeonidis, Arpad Illes, Gabor Mikala, Zsolt Nagy, Sara Bringen, Paolo Corradini, Ciceri Fabio, Roberto Lemoli, Anna Liberati, Chiara Nozzoli, Renato Zambello, Shinsuke Iida, Takashi Ikeda, Satoshi Iyama, Morio Matsumoto, Chihiro Shimazaki, Kazutaka Sunami, Kenshi Suzuki, Michihiro Uchiyama, Youngil Koh, Kihyun Kim, Jae Hoon Lee, Chang Ki Min, Hillary Blacklock, Hugh Goodman, Annette Neylon, David Simpson, Sebastian Grosicki, Artur Jurczyszyn, Adam Walter-Croneck, Krzysztof Warzocha, Luis Araujo, Claudia Moreira, Vadim Doronin, Larisa Mendeleeva, Vladimir Vorobyev, Andrej Vranovsky, Adrian Alegre, Mercedes Gironella, Marta Sonia Gonzalez Perez, Carmen Montes, Enrique Ocio, Paula Rodriguez, Mats Hardling, Birgitta Lauri, Ming Chung Wang, Su Peng Yeh, Mutlu Arat, Fatih Demirkan, Zafer Gulbas, Sevgi Kalayoglu Besisik, Ihsan Karadogan, Tulin Tuglular, Ali Unal, Filiz Vural, Jonathan Sive, Matthew Streetly, Kwee Yong, Jason Tache
  • Institut Universitaire du Cancer Toulouse Oncopole
  • Harvard University
  • Mayo Clinic Rochester, MN
  • University of Navarra
  • Ankara University
  • Charles University
  • CHU de Poitiers
  • University of Oslo
  • Nantes University
  • National and Kapodistrian University of Athens
  • National Taiwan University
  • Palacký University Olomouc
  • University of Bologna
  • University of Melbourne
  • Sanofi-Aventis
  • Genzyme Corporation

Research output: Contribution to journal › Article › peer-review

582   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology